Salient Bio is a young, fast-growing biotech start-up that operates at the intersection of synthetic biology and robotics. Born with the vision of making diagnostics accessible to all, we design, build and operate automated molecular diagnostic platforms. Salient Bio is based in central London, where it has built a state-of-the-art laboratory and is operating its first commercially successful platform for high-throughput COVID-19 testing. This represents a small but important step in our journey to transform the delivery of mass-scale diagnostics to communities around the world.